Push the boundaries of what is possible with pristine synthetic DNA
Tuesday, July 15, 2025 at 15:00 BST / 16:00 CEST / 10:00 EDT / 07:00 PDT
Biopharma and life sciences demand DNA synthesis technologies that are highly accurate, flexible, and built for complexity. Join Dr. John Luckey and Divya Vijay Pratheek to explore how Ribbon Bio’s MiroSynth™ DNA delivers high-fidelity, long synthetic DNA through intelligent algorithms, enzymatic assembly, and automation. Designed for both linear and circular constructs, MiroSynth™ enables full traceability from sequence to molecule. This feature empowers researchers with confidence in every base.
Attendees will learn how Ribbon Bio is accelerating therapeutic development and will hear from Syngoi Technologies on how both companies are working together to make scalable synthetic DNA a reality for biopharma and life sciences.
Key learning objectives
- Discover how MiroSynth™ combines enzymatic assembly, automation, and intelligent algorithms for high-precision DNA synthesis.
- Learn how Ribbon supports both linear and circular DNA for advanced biopharma needs.
- See how end-to-end synthesis accelerates research and improves reliability.
- Understand how Ribbon has partnered with Syngoi Technologies to enable gram-scale DNA production for therapeutic development.
Who should attend?
- Heads of research and development
- Lab professionals
Certificate of attendance
If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.
Speakers
Dr. John Luckey brings over 25 years of experience in leading biotechnology platform development for biomedical research and translational medicine. He has held senior roles at Roche NimbleGen, RainDance Technologies, and DNA Script, and founded GeneSys Technologies. He holds a Ph.D. in Analytical Chemistry and an MBA from the University of Wisconsin-Madison.
Divya Vijay Pratheek is a biotechnology leader with over a decade of experience in global product and commercial strategy. She has held key roles at QIAGEN, Automata, and Congenica, where she led cross-functional teams across automation, reagents, and software. Her background in science and communication supports the intersection of biotech innovation and strategic product development.
José has more than 25 years of managing experience of high growth biotech companies. Currently serving as CEO of Syngoi Technologies its expertise is to develop CDMO companies for advanced therapies specialized in synthetic DNA or Drug Delivery Systems among others. José is also a Business Angel investor and founder of multiple biotech companies.
Julen Oyarzabal, Ph.D., has over 20 years’ experience as a scientific leader and is Founder and Chief Scientific Officer of Syngoi Technologies, a company focused on the manufacturing of synthetic DNA. Julen also serves as CSO Partner at Columbus Venture Partners.
Moderator
